Who Paid My Doc
Option
ClinicalTrials.gov NCT03795298
Research payments
$8,512,257
Through program year 2025, $8,512,257 in research payments was reported against Option, across 3,141 payments, paid by Boston Scientific Corporation.
- Paid by
- Boston Scientific Corporation
- ClinicalTrials.gov
- NCT03795298
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $248,290 | 101 |
| 2024 | Research | $890,182 | 439 |
| 2023 | Research | $1,509,998 | 628 |
| 2022 | Research | $1,692,519 | 757 |
| 2021 | Research | $1,685,221 | 595 |
| 2020 | Research | $2,486,047 | 621 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Chinmay Patel Harrisburg, PA Named on 53 payments
- James Deville Plano, TX Named on 45 payments
- Devi Nair Jonesboro, AR Named on 39 payments
- Manish Shah Washington, DC Named on 39 payments
- Srikanth Sundaram Littleton, CO Named on 37 payments
- Douglas Gibson La Jolla, CA Named on 35 payments
- Jeffrey Olson Indianapolis, IN Named on 34 payments
- Moeen Saleem Naperville, IL Named on 34 payments
- Christopher Woods Burlingame, CA Named on 34 payments
- Troy Hounshell West Des Moines, IA Named on 34 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.